Syndax Pharmaceuticals Inc. (SNDX) NASDAQ

$23.07 1.63 (7.60%)

Market Cap: $1.96B

As of 03/27/24 04:00 PM EDT. Market closed.

(SNDX)

Syndax Pharmaceuticals Inc. (SNDX)
NASDAQ

$23.07
1.63 (7.60%)

Market Cap: $1.96B

As of 03/27/24 04:00 PM EDT. Market closed.

Add to Portfolio

syndax pharmaceuticals is a biotechnology company located at 35 gatehouse dr., building d, floor 3, waltham, ma ... read more

syndax pharmaceuticals is a biotechnology company located at 35 gatehouse dr., building d, floor 3, waltham, ma 02451. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Briggs Morrison
Full Time Employees
112
CEO Compensation (Base)
$566,073
CEO Compensation (Total)
$2.08M
URL
Address
Building D, 35 Gatehouse Dr Fl 3, Massachusetts, Waltham, 02451-1215.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Briggs Morrison
Full Time Employees
112
CEO Compensation (Base)
$566,073
CEO Compensation (Total)
$2.08M
Address
Building D, 35 Gatehouse Dr Fl 3, Massachusetts, Waltham, 02451-1215.
PRICE CHART FOR SYNDAX PHARMACEUTICALS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$21.44
Days Range
$21.79 - $23.25
52 week range
$11.22 - $25.34
Volume
101
Avg. Volume (30 days)
1,330,426
Market Cap
$1.96B
Dividend Yield
-
P/E
(140.55)
Shares Outstanding
84,965,486
Open
-
Previous Close
$21.44
Days Range
$21.79 - $23.25
52 week range
$11.22 - $25.34
Volume
101
Avg. Volume (30 days)
1,330,426
Market Cap
$1.96B
Dividend Yield
-
P/E
(140.55)
Shares Outstanding
84,965,486
FINANCIAL STATEMENTS FOR SYNDAX PHARMACEUTICALS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR SYNDAX PHARMACEUTICALS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Goldan Keith A.Chief Financial OfficerJan 31, 2024 Option Exercise$17.421,18320,6084,673Feb 09, 2024, 04:05 PM
Goldan Keith A.Chief Financial OfficerJul 31, 2023 Option Exercise$18.1286215,6193,490Feb 09, 2024, 04:05 PM
Morrison BriggsDirectorAug 09, 2023 Option Exercise$8.7752,855463,53870,691Aug 10, 2023, 06:50 AM
Morrison BriggsDirectorAug 09, 2023 Sale$18.2752,855965,40217,836Aug 10, 2023, 06:50 AM
Meury WilliamDirectorAug 02, 2023 Option Exercise$8.0283,000665,25083,000Aug 03, 2023, 09:12 AM
Meury WilliamDirectorAug 02, 2023 Sale$20.4683,0001,697,81048,000Aug 03, 2023, 09:12 AM
Morrison BriggsDirectorJul 10, 2023 Option Exercise$8.7752,855463,53870,691Jul 11, 2023, 09:23 AM
Morrison BriggsDirectorJul 10, 2023 Sale$20.4052,8551,078,06817,836Jul 11, 2023, 09:23 AM
Goldan Keith A.Chief Financial OfficerJun 13, 2023 Sale$22.3157712,8732,628Jun 14, 2023, 04:20 PM
Morrison BriggsDirectorJun 09, 2023 Option Exercise$7.6652,855404,78770,691Jun 09, 2023, 05:32 PM
Morrison BriggsDirectorJun 09, 2023 Sale$21.1852,8551,119,42146,109Jun 09, 2023, 05:32 PM
Morrison BriggsDirectorMay 09, 2023 Option Exercise$6.3852,855337,21570,691May 10, 2023, 04:11 PM
Morrison BriggsDirectorMay 09, 2023 Sale$21.4152,8551,131,47817,836May 10, 2023, 04:11 PM
Morrison BriggsDirectorApr 10, 2023 Option Exercise$6.3852,855337,21570,691Apr 12, 2023, 04:03 PM
Morrison BriggsDirectorApr 10, 2023 Sale$19.5352,8551,032,23717,836Apr 12, 2023, 04:03 PM
Morrison BriggsPresident, Head of R&DMar 13, 2023 Option Exercise$6.3852,854337,20970,690Mar 14, 2023, 04:42 PM
Morrison BriggsPresident, Head of R&DMar 13, 2023 Sale$22.5352,8541,190,67417,836Mar 14, 2023, 04:42 PM
Ordentlich PeterChief Scientific OfficerFeb 15, 2023 Option Exercise$6.9525,000173,79117,428Feb 17, 2023, 06:09 PM
Ordentlich PeterChief Scientific OfficerFeb 15, 2023 Sale$25.8425,000646,0930Feb 17, 2023, 06:09 PM
Metzger Michael AChief Executive OfficerFeb 06, 2023 Option Exercise$6.385,95938,01823,618Feb 08, 2023, 04:49 PM
Metzger Michael AChief Executive OfficerFeb 06, 2023 Sale$27.645,959164,69717,659Feb 08, 2023, 04:49 PM
Morrison BriggsPresident, Head of R&DFeb 06, 2023 Option Exercise$6.3852,854337,20970,690Feb 08, 2023, 04:49 PM
Morrison BriggsPresident, Head of R&DFeb 06, 2023 Sale$26.8352,8541,417,90917,836Feb 08, 2023, 04:49 PM
Ordentlich PeterChief Scientific OfficerJan 31, 2023 Option Exercise$17.32691,19569Feb 03, 2023, 04:59 PM
Ordentlich PeterChief Scientific OfficerFeb 01, 2023 Sale$28.43691,9620Feb 03, 2023, 04:59 PM
Legault PierreDirectorJan 13, 2023 Option Exercise$13.5815,000203,70042,000Jan 13, 2023, 04:44 PM
Legault PierreDirectorJan 12, 2023 Option Exercise$9.4724,000227,28056,000Jan 13, 2023, 04:44 PM
Legault PierreDirectorJan 13, 2023 Sale$27.0015,000405,00032,000Jan 13, 2023, 04:44 PM
Legault PierreDirectorJan 12, 2023 Sale$26.7424,000641,78232,000Jan 13, 2023, 04:44 PM
Ordentlich PeterChief Scientific OfficerDec 01, 2022 Option Exercise$6.377,80049,6514,293Dec 02, 2022, 05:01 PM
Ordentlich PeterChief Scientific OfficerDec 02, 2022 Option Exercise$6.3817,200109,73617,465Dec 02, 2022, 05:01 PM
Ordentlich PeterChief Scientific OfficerDec 01, 2022 Sale$25.017,800195,089265Dec 02, 2022, 05:01 PM
Ordentlich PeterChief Scientific OfficerDec 02, 2022 Sale$25.0517,200430,936265Dec 02, 2022, 05:01 PM
Katkin KeithDirectorOct 06, 2022 Option Exercise$8.2029,899245,17752,782Oct 07, 2022, 04:05 PM
Katkin KeithDirectorOct 06, 2022 Sale$25.9029,899774,41132,000Oct 07, 2022, 04:05 PM
Metzger Michael AChief Executive OfficerOct 06, 2022 Option Exercise$8.7716,231142,34633,890Oct 07, 2022, 04:05 PM
Metzger Michael AChief Executive OfficerOct 06, 2022 Sale$25.2916,231410,50817,659Oct 07, 2022, 04:05 PM
Metzger Michael AChief Executive OfficerOct 03, 2022 Option Exercise$8.772,88325,28420,542Oct 04, 2022, 05:49 PM
Metzger Michael AChief Executive OfficerSep 30, 2022 Option Exercise$8.7729,606259,64547,265Oct 04, 2022, 05:49 PM
Metzger Michael AChief Executive OfficerOct 04, 2022 Option Exercise$8.771,28011,22618,939Oct 04, 2022, 05:49 PM
Metzger Michael AChief Executive OfficerOct 03, 2022 Sale$25.012,88372,10717,659Oct 04, 2022, 05:49 PM
Metzger Michael AChief Executive OfficerSep 30, 2022 Sale$25.0229,606740,75717,659Oct 04, 2022, 05:49 PM
Metzger Michael AChief Executive OfficerOct 04, 2022 Sale$25.021,28032,02617,659Oct 04, 2022, 05:49 PM
Katkin KeithDirectorOct 04, 2022 Option Exercise$8.533603,07132,223Oct 04, 2022, 05:49 PM
Katkin KeithDirectorOct 03, 2022 Option Exercise$7.961801,43232,167Oct 04, 2022, 05:49 PM
Katkin KeithDirectorSep 30, 2022 Option Exercise$8.073,56128,74034,914Oct 04, 2022, 05:49 PM
Katkin KeithDirectorOct 03, 2022 Sale$25.001804,50032,000Oct 04, 2022, 05:49 PM
Katkin KeithDirectorSep 30, 2022 Sale$25.073,56189,27732,000Oct 04, 2022, 05:49 PM
Katkin KeithDirectorOct 04, 2022 Sale$25.003609,00032,000Oct 04, 2022, 05:49 PM
Morrison BriggsPresident, Head of R&DSep 19, 2022 Option Exercise$10.90114,3391,246,295132,175Sep 21, 2022, 04:18 PM
Morrison BriggsPresident, Head of R&DSep 20, 2022 Option Exercise$10.9059,649650,17477,485Sep 21, 2022, 04:18 PM
Morrison BriggsPresident, Head of R&DSep 19, 2022 Sale$23.03114,3392,633,04417,836Sep 21, 2022, 04:18 PM
Morrison BriggsPresident, Head of R&DSep 20, 2022 Sale$23.2559,6491,387,01217,836Sep 21, 2022, 04:18 PM
Morrison BriggsPresident, Head of R&DSep 16, 2022 Option Exercise$8.77125,0001,096,22689,802Sep 16, 2022, 05:34 PM
Morrison BriggsPresident, Head of R&DSep 15, 2022 Option Exercise$7.2066,775480,78084,611Sep 16, 2022, 05:34 PM
Morrison BriggsPresident, Head of R&DSep 14, 2022 Option Exercise$7.2087,645631,044105,481Sep 16, 2022, 05:34 PM
Morrison BriggsPresident, Head of R&DSep 16, 2022 Sale$23.22125,0002,902,43717,836Sep 16, 2022, 05:34 PM
Morrison BriggsPresident, Head of R&DSep 15, 2022 Sale$24.2066,7751,616,03517,836Sep 16, 2022, 05:34 PM
Morrison BriggsPresident, Head of R&DSep 14, 2022 Sale$23.8087,6452,085,85517,836Sep 16, 2022, 05:34 PM
Podlesak DennisDirectorSep 16, 2022 Option Exercise$6.3411,97575,87982,319Sep 16, 2022, 05:34 PM
Podlesak DennisDirectorSep 15, 2022 Option Exercise$6.3266,840422,429142,603Sep 16, 2022, 05:34 PM
Podlesak DennisDirectorSep 16, 2022 Sale$23.4311,975280,60775,763Sep 16, 2022, 05:34 PM
Podlesak DennisDirectorSep 15, 2022 Sale$24.2066,8401,617,38175,763Sep 16, 2022, 05:34 PM
Ordentlich PeterChief Scientific OfficerJul 29, 2022 Option Exercise$14.122653,742265Aug 26, 2022, 04:14 PM
Ordentlich PeterChief Scientific OfficerAug 24, 2022 Option Exercise$6.3225,000158,06523,111Aug 26, 2022, 04:14 PM
Ordentlich PeterChief Scientific OfficerAug 24, 2022 Sale$25.0425,000625,892265Aug 26, 2022, 04:14 PM
Legault PierreDirectorAug 05, 2022 Option Exercise$9.2224,000221,32046,000Aug 09, 2022, 04:05 PM
Legault PierreDirectorAug 05, 2022 Sale$23.0224,000552,38232,000Aug 09, 2022, 04:05 PM
Metzger Michael AChief Executive OfficerJul 25, 2022 Option Exercise$6.3831,602201,62137,423Jul 27, 2022, 06:42 PM
Metzger Michael AChief Executive OfficerJul 25, 2022 Sale$21.0631,602665,39317,659Jul 27, 2022, 06:42 PM
Metzger Michael AChief Executive OfficerJul 07, 2022 Option Exercise$6.3810063817,759Jul 08, 2022, 05:51 PM
Metzger Michael AChief Executive OfficerJul 06, 2022 Option Exercise$6.3815,00995,75732,668Jul 08, 2022, 05:51 PM
Metzger Michael AChief Executive OfficerJul 07, 2022 Sale$21.001002,10017,659Jul 08, 2022, 05:51 PM
Metzger Michael AChief Executive OfficerJul 06, 2022 Sale$21.0715,009316,30717,659Jul 08, 2022, 05:51 PM
Morrison BriggsPresident, Head of R&DApr 04, 2022 Option Exercise$7.203,12822,52220,964Apr 13, 2022, 04:09 PM
Morrison BriggsPresident, Head of R&DApr 01, 2022 Option Exercise$7.2070,545507,92488,381Apr 13, 2022, 04:09 PM
Morrison BriggsPresident, Head of R&DApr 04, 2022 Option Exercise$10.903,12834,09520,964Apr 05, 2022, 04:05 PM
Morrison BriggsPresident, Head of R&DApr 01, 2022 Option Exercise$10.9070,545768,94088,381Apr 05, 2022, 04:05 PM
Morrison BriggsPresident, Head of R&DApr 01, 2022 Sale$17.45101,0451,763,51542,336Apr 05, 2022, 04:05 PM
Morrison BriggsPresident, Head of R&DApr 04, 2022 Sale$18.293,12857,22017,836Apr 05, 2022, 04:05 PM
Ordentlich PeterChief Scientific OfficerJan 31, 2022 Option Exercise$12.391,41217,4951,412Feb 03, 2022, 05:32 PM
Ordentlich PeterChief Scientific OfficerFeb 01, 2022 Sale$16.651,41223,5100Feb 03, 2022, 05:32 PM
Meyers Michael L.SVP, Chief Medical OfficerJan 31, 2022 Option Exercise$12.391,71421,23623,280Feb 03, 2022, 05:31 PM
Nolte AlexanderChief Accounting OfficerJan 31, 2022 Option Exercise$12.3996811,994968Feb 03, 2022, 05:31 PM
Nolte AlexanderChief Accounting OfficerFeb 01, 2022 Sale$16.6596816,1170Feb 03, 2022, 05:31 PM
Meyers Michael L.SVP, Chief Medical OfficerDec 30, 2021 Option Exercise$8.775,90051,74321,566Jan 03, 2022, 04:03 PM
Legault PierreDirectorDec 20, 2021 Option Exercise$7.0820,000141,60036,000Dec 22, 2021, 06:25 PM
Legault PierreDirectorDec 22, 2021 Option Exercise$7.8824,000189,12040,000Dec 22, 2021, 06:25 PM
Legault PierreDirectorDec 22, 2021 Sale$22.0124,000528,20616,000Dec 22, 2021, 06:25 PM
Legault PierreDirectorDec 20, 2021 Sale$21.0120,000420,25016,000Dec 22, 2021, 06:25 PM
Morrison BriggsChief Executive OfficerDec 17, 2021 Option Exercise$10.9035,156383,20083,492Dec 20, 2021, 06:44 PM
Morrison BriggsChief Executive OfficerDec 17, 2021 Sale$20.0035,156703,12048,336Dec 20, 2021, 06:44 PM
Metzger Michael APresident and COODec 20, 2021 Option Exercise$8.1461,000496,73062,659Dec 20, 2021, 06:44 PM
Metzger Michael APresident and COODec 17, 2021 Option Exercise$6.381,67610,69319,335Dec 20, 2021, 06:44 PM
Metzger Michael APresident and COODec 16, 2021 Option Exercise$6.3822,715144,92240,374Dec 20, 2021, 06:44 PM
Metzger Michael APresident and COODec 20, 2021 Sale$20.2961,0001,237,56817,659Dec 20, 2021, 06:44 PM
Metzger Michael APresident and COODec 17, 2021 Sale$19.021,67631,87717,659Dec 20, 2021, 06:44 PM
Metzger Michael APresident and COODec 16, 2021 Sale$19.0822,715433,40017,659Dec 20, 2021, 06:44 PM
Metzger Michael APresident and COODec 13, 2021 Option Exercise$6.4336,609235,24252,223Dec 15, 2021, 05:35 PM
Metzger Michael APresident and COODec 13, 2021 Sale$19.0536,609697,51917,659Dec 15, 2021, 05:35 PM
Egros FabriceDirectorNov 18, 2021 Option Exercise$8.9314,030125,25630,000Nov 19, 2021, 04:06 PM
Egros FabriceDirectorNov 18, 2021 Sale$18.0314,030252,99316,000Nov 19, 2021, 04:06 PM
Metzger Michael APresident and COOOct 26, 2021 Option Exercise$7.2016,296117,33133,955Oct 27, 2021, 04:11 PM
Metzger Michael APresident and COOOct 25, 2021 Option Exercise$7.2044,704321,86962,363Oct 27, 2021, 04:11 PM
Metzger Michael APresident and COOOct 25, 2021 Sale$19.1344,704855,33517,659Oct 27, 2021, 04:11 PM
Metzger Michael APresident and COOOct 26, 2021 Sale$19.2016,296312,82517,659Oct 27, 2021, 04:11 PM
Metzger Michael APresident and COOSep 27, 2021 Option Exercise$7.2024,437175,94642,096Sep 28, 2021, 04:36 PM
Metzger Michael APresident and COOSep 27, 2021 Sale$19.5124,437476,83217,659Sep 28, 2021, 04:36 PM
Metzger Michael APresident and COOSep 22, 2021 Option Exercise$7.203002,16017,959Sep 22, 2021, 04:50 PM
Metzger Michael APresident and COOSep 21, 2021 Option Exercise$7.204,80834,61822,467Sep 22, 2021, 04:50 PM
Metzger Michael APresident and COOSep 20, 2021 Option Exercise$7.2031,455226,47649,114Sep 22, 2021, 04:50 PM
Metzger Michael APresident and COOSep 21, 2021 Sale$19.164,80892,10817,659Sep 22, 2021, 04:50 PM
Metzger Michael APresident and COOSep 20, 2021 Sale$19.2431,455605,04617,659Sep 22, 2021, 04:50 PM
Metzger Michael APresident and COOSep 22, 2021 Sale$19.023005,70617,659Sep 22, 2021, 04:50 PM
Morrison BriggsChief Executive OfficerSep 17, 2021 Option Exercise$7.2070,262505,886118,598Sep 21, 2021, 04:35 PM
Morrison BriggsChief Executive OfficerSep 20, 2021 Option Exercise$7.205036048,386Sep 21, 2021, 04:35 PM
Morrison BriggsChief Executive OfficerSep 17, 2021 Sale$20.0770,2621,410,01848,336Sep 21, 2021, 04:35 PM
Morrison BriggsChief Executive OfficerSep 20, 2021 Sale$20.00501,00048,336Sep 21, 2021, 04:35 PM
Metzger Michael APresident and COOSep 14, 2021 Option Exercise$7.2044,349319,31362,008Sep 15, 2021, 04:16 PM
Metzger Michael APresident and COOSep 13, 2021 Option Exercise$7.2016,651119,88734,310Sep 15, 2021, 04:16 PM
Metzger Michael APresident and COOSep 14, 2021 Sale$19.1544,349849,39417,659Sep 15, 2021, 04:16 PM
Metzger Michael APresident and COOSep 13, 2021 Sale$19.0216,651316,63917,659Sep 15, 2021, 04:16 PM
Egros FabriceDirectorAug 18, 2021 Option Exercise$7.8815,635123,20431,635Aug 20, 2021, 04:32 PM
Egros FabriceDirectorAug 18, 2021 Sale$15.7515,635246,32816,000Aug 20, 2021, 04:32 PM
Egros FabriceDirectorMay 18, 2021 Option Exercise$7.2813,60999,12929,609May 20, 2021, 04:46 PM
Egros FabriceDirectorMay 18, 2021 Sale$18.6513,609253,78317,683May 20, 2021, 04:46 PM
Meyers Michael L.SVP, Chief Medical OfficerApr 26, 2021 Buy$15.465007,73015,666Apr 28, 2021, 04:15 PM
Podlesak DennisDirectorApr 22, 2021 Buy$14.1113,967197,07743,300Apr 22, 2021, 05:06 PM
Egros FabriceDirectorMar 01, 2021 Option Exercise$6.3610,24165,09326,241Mar 03, 2021, 04:16 PM
Egros FabriceDirectorMar 01, 2021 Sale$24.3110,241248,98116,074Mar 03, 2021, 04:16 PM
Morrison BriggsChief Executive OfficerFeb 08, 2021 Option Exercise$7.2035,156253,12383,492Feb 10, 2021, 04:23 PM
Morrison BriggsChief Executive OfficerFeb 08, 2021 Sale$20.5535,156722,40348,336Feb 10, 2021, 04:23 PM
Morrison BriggsChief Executive OfficerJan 31, 2021 Option Exercise$12.001,77121,25248,336Feb 05, 2021, 04:21 PM
Meyers Michael L.SVP, Chief Medical OfficerJan 31, 2021 Option Exercise$12.001,77121,25215,166Feb 05, 2021, 04:21 PM
Meyers Michael L.SVP, Chief Medical OfficerJul 31, 2020 Option Exercise$7.972,66521,24013,395Feb 05, 2021, 04:21 PM
Metzger Michael APresident and COOFeb 01, 2021 Option Exercise$7.2015,000108,00032,659Feb 03, 2021, 05:53 PM
Metzger Michael APresident and COOFeb 01, 2021 Sale$20.1915,000302,79917,659Feb 03, 2021, 05:53 PM
Metzger Michael APresident and COODec 01, 2020 Option Exercise$7.2015,000108,00032,659Dec 03, 2020, 06:05 PM
Metzger Michael APresident and COODec 01, 2020 Sale$22.9715,000344,51317,659Dec 03, 2020, 06:05 PM
Ordentlich PeterChief Scientific OfficerNov 23, 2020 Option Exercise$3.0829,97292,31429,972Nov 25, 2020, 04:38 PM
Ordentlich PeterChief Scientific OfficerNov 23, 2020 Sale$23.1629,972694,12124,288Nov 25, 2020, 04:38 PM
Morrison BriggsChief Executive OfficerNov 10, 2020 Option Exercise$7.2017,466125,75564,031Nov 12, 2020, 05:55 PM
Morrison BriggsChief Executive OfficerNov 09, 2020 Option Exercise$7.2062,938453,154109,503Nov 12, 2020, 05:55 PM
Morrison BriggsChief Executive OfficerNov 10, 2020 Sale$20.0617,466350,31246,565Nov 12, 2020, 05:55 PM
Morrison BriggsChief Executive OfficerNov 09, 2020 Sale$20.0462,9381,261,26546,565Nov 12, 2020, 05:55 PM
Metzger Michael APresident and COONov 04, 2020 Option Exercise$7.20100,000720,000117,659Nov 06, 2020, 05:55 PM
Metzger Michael APresident and COONov 04, 2020 Sale$20.31100,0002,031,41017,659Nov 06, 2020, 05:55 PM
Shea Richard PChief Financial OfficerJul 31, 2019 Option Exercise$4.891,4016,8515,616Feb 14, 2020, 04:37 PM
Shea Richard PChief Financial OfficerJan 31, 2020 Option Exercise$7.971,50511,9957,121Feb 14, 2020, 04:37 PM
Morrison BriggsChief Executive OfficerFeb 04, 2020 Buy$8.0012,500100,00043,900Feb 05, 2020, 04:07 PM
Morrison BriggsChief Executive OfficerOct 10, 2019 Buy$5.4011,00059,40031,400Oct 11, 2019, 06:33 AM
Morrison BriggsChief Executive OfficerMay 13, 2019 Buy$7.297,20052,51720,400May 13, 2019, 04:11 PM
Morrison BriggsChief Executive OfficerMay 09, 2019 Buy$7.5513,20099,72613,200May 13, 2019, 04:11 PM
Meyers Michael L.SVP, Chief Medical OfficerMar 21, 2019 Buy$4.878397,230Mar 25, 2019, 04:03 PM
Meyers Michael L.SVP, Chief Medical OfficerMar 21, 2019 Buy$4.921,1045,4367,222Mar 22, 2019, 04:05 PM
Shea Richard PChief Financial OfficerJan 31, 2019 Option Exercise$4.762,52112,0004,215Feb 08, 2019, 04:27 PM
Meyers Michael L.SVP, Chief Medical OfficerJan 31, 2019 Option Exercise$4.763,72017,7076,118Feb 08, 2019, 04:27 PM
Metzger Michael APresident and COOJan 31, 2019 Option Exercise$4.762,65912,6572,659Feb 08, 2019, 04:27 PM
Meyers Michael L.SVP, Chief Medical OfficerOct 30, 2018 Buy$4.792009582,398Nov 07, 2018, 04:02 PM
Ordentlich PeterChief Scientific OfficerApr 03, 2018 Option Exercise$3.087,50023,1007,500Apr 03, 2018, 04:42 PM
Ordentlich PeterChief Scientific OfficerApr 03, 2018 Sale$15.007,500112,5000Apr 03, 2018, 04:42 PM
Ordentlich PeterChief Scientific OfficerMay 17, 2017 Option Exercise$3.087322,2555,000May 19, 2017, 11:27 AM
Ordentlich PeterChief Scientific OfficerMay 17, 2017 Sale$15.005,00075,0000May 19, 2017, 11:27 AM
ROYSTON IVORDirectorMar 20, 2017 Option Exercise$13.75125,0001,718,750625,545Mar 22, 2017, 01:37 PM
ROYSTON IVORDirectorMar 08, 2016 Buy$12.00150,0001,800,000750,545Mar 08, 2016, 06:38 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Goldan Keith A.Chief Financial Officer01/31/202420,608
Goldan Keith A.Chief Financial Officer07/31/202315,619
Morrison BriggsDirector08/09/2023463,538
Morrison BriggsDirector08/09/2023965,402
Meury WilliamDirector08/02/2023665,250
Meury WilliamDirector08/02/20231,697,810
Morrison BriggsDirector07/10/2023463,538
Morrison BriggsDirector07/10/20231,078,068
Goldan Keith A.Chief Financial Officer06/13/202312,873
Morrison BriggsDirector06/09/2023404,787
Morrison BriggsDirector06/09/20231,119,421
Morrison BriggsDirector05/09/2023337,215
Morrison BriggsDirector05/09/20231,131,478
Morrison BriggsDirector04/10/2023337,215
Morrison BriggsDirector04/10/20231,032,237
Morrison BriggsPresident, Head of R&D03/13/2023337,209
Morrison BriggsPresident, Head of R&D03/13/20231,190,674
Ordentlich PeterChief Scientific Officer02/15/2023173,791
Ordentlich PeterChief Scientific Officer02/15/2023646,093
Metzger Michael AChief Executive Officer02/06/202338,018
Metzger Michael AChief Executive Officer02/06/2023164,697
Morrison BriggsPresident, Head of R&D02/06/2023337,209
Morrison BriggsPresident, Head of R&D02/06/20231,417,909
Ordentlich PeterChief Scientific Officer01/31/20231,195
Ordentlich PeterChief Scientific Officer02/01/20231,962
Legault PierreDirector01/13/2023203,700
Legault PierreDirector01/12/2023227,280
Legault PierreDirector01/13/2023405,000
Legault PierreDirector01/12/2023641,782
Ordentlich PeterChief Scientific Officer12/01/202249,651
Ordentlich PeterChief Scientific Officer12/02/2022109,736
Ordentlich PeterChief Scientific Officer12/01/2022195,089
Ordentlich PeterChief Scientific Officer12/02/2022430,936
Katkin KeithDirector10/06/2022245,177
Katkin KeithDirector10/06/2022774,411
Metzger Michael AChief Executive Officer10/06/2022142,346
Metzger Michael AChief Executive Officer10/06/2022410,508
Metzger Michael AChief Executive Officer10/03/202225,284
Metzger Michael AChief Executive Officer09/30/2022259,645
Metzger Michael AChief Executive Officer10/04/202211,226
Metzger Michael AChief Executive Officer10/03/202272,107
Metzger Michael AChief Executive Officer09/30/2022740,757
Metzger Michael AChief Executive Officer10/04/202232,026
Katkin KeithDirector10/04/20223,071
Katkin KeithDirector10/03/20221,432
Katkin KeithDirector09/30/202228,740
Katkin KeithDirector10/03/20224,500
Katkin KeithDirector09/30/202289,277
Katkin KeithDirector10/04/20229,000
Morrison BriggsPresident, Head of R&D09/19/20221,246,295
Morrison BriggsPresident, Head of R&D09/20/2022650,174
Morrison BriggsPresident, Head of R&D09/19/20222,633,044
Morrison BriggsPresident, Head of R&D09/20/20221,387,012
Morrison BriggsPresident, Head of R&D09/16/20221,096,226
Morrison BriggsPresident, Head of R&D09/15/2022480,780
Morrison BriggsPresident, Head of R&D09/14/2022631,044
Morrison BriggsPresident, Head of R&D09/16/20222,902,437
Morrison BriggsPresident, Head of R&D09/15/20221,616,035
Morrison BriggsPresident, Head of R&D09/14/20222,085,855
Podlesak DennisDirector09/16/202275,879
Podlesak DennisDirector09/15/2022422,429
Podlesak DennisDirector09/16/2022280,607
Podlesak DennisDirector09/15/20221,617,381
Ordentlich PeterChief Scientific Officer07/29/20223,742
Ordentlich PeterChief Scientific Officer08/24/2022158,065
Ordentlich PeterChief Scientific Officer08/24/2022625,892
Legault PierreDirector08/05/2022221,320
Legault PierreDirector08/05/2022552,382
Metzger Michael AChief Executive Officer07/25/2022201,621
Metzger Michael AChief Executive Officer07/25/2022665,393
Metzger Michael AChief Executive Officer07/07/2022638
Metzger Michael AChief Executive Officer07/06/202295,757
Metzger Michael AChief Executive Officer07/07/20222,100
Metzger Michael AChief Executive Officer07/06/2022316,307
Morrison BriggsPresident, Head of R&D04/04/202222,522
Morrison BriggsPresident, Head of R&D04/01/2022507,924
Morrison BriggsPresident, Head of R&D04/04/202234,095
Morrison BriggsPresident, Head of R&D04/01/2022768,940
Morrison BriggsPresident, Head of R&D04/01/20221,763,515
Morrison BriggsPresident, Head of R&D04/04/202257,220
Ordentlich PeterChief Scientific Officer01/31/202217,495
Ordentlich PeterChief Scientific Officer02/01/202223,510
Meyers Michael L.SVP, Chief Medical Officer01/31/202221,236
Nolte AlexanderChief Accounting Officer01/31/202211,994
Nolte AlexanderChief Accounting Officer02/01/202216,117
Meyers Michael L.SVP, Chief Medical Officer12/30/202151,743
Legault PierreDirector12/20/2021141,600
Legault PierreDirector12/22/2021189,120
Legault PierreDirector12/22/2021528,206
Legault PierreDirector12/20/2021420,250
Morrison BriggsChief Executive Officer12/17/2021383,200
Morrison BriggsChief Executive Officer12/17/2021703,120
Metzger Michael APresident and COO12/20/2021496,730
Metzger Michael APresident and COO12/17/202110,693
Metzger Michael APresident and COO12/16/2021144,922
Metzger Michael APresident and COO12/20/20211,237,568
Metzger Michael APresident and COO12/17/202131,877
Metzger Michael APresident and COO12/16/2021433,400
Metzger Michael APresident and COO12/13/2021235,242
Metzger Michael APresident and COO12/13/2021697,519
Egros FabriceDirector11/18/2021125,256
Egros FabriceDirector11/18/2021252,993
Metzger Michael APresident and COO10/26/2021117,331
Metzger Michael APresident and COO10/25/2021321,869
Metzger Michael APresident and COO10/25/2021855,335
Metzger Michael APresident and COO10/26/2021312,825
Metzger Michael APresident and COO09/27/2021175,946
Metzger Michael APresident and COO09/27/2021476,832
Metzger Michael APresident and COO09/22/20212,160
Metzger Michael APresident and COO09/21/202134,618
Metzger Michael APresident and COO09/20/2021226,476
Metzger Michael APresident and COO09/21/202192,108
Metzger Michael APresident and COO09/20/2021605,046
Metzger Michael APresident and COO09/22/20215,706
Morrison BriggsChief Executive Officer09/17/2021505,886
Morrison BriggsChief Executive Officer09/20/2021360
Morrison BriggsChief Executive Officer09/17/20211,410,018
Morrison BriggsChief Executive Officer09/20/20211,000
Metzger Michael APresident and COO09/14/2021319,313
Metzger Michael APresident and COO09/13/2021119,887
Metzger Michael APresident and COO09/14/2021849,394
Metzger Michael APresident and COO09/13/2021316,639
Egros FabriceDirector08/18/2021123,204
Egros FabriceDirector08/18/2021246,328
Egros FabriceDirector05/18/202199,129
Egros FabriceDirector05/18/2021253,783
Meyers Michael L.SVP, Chief Medical Officer04/26/20217,730
Podlesak DennisDirector04/22/2021197,077
Egros FabriceDirector03/01/202165,093
Egros FabriceDirector03/01/2021248,981
Morrison BriggsChief Executive Officer02/08/2021253,123
Morrison BriggsChief Executive Officer02/08/2021722,403
Morrison BriggsChief Executive Officer01/31/202121,252
Meyers Michael L.SVP, Chief Medical Officer01/31/202121,252
Meyers Michael L.SVP, Chief Medical Officer07/31/202021,240
Metzger Michael APresident and COO02/01/2021108,000
Metzger Michael APresident and COO02/01/2021302,799
Metzger Michael APresident and COO12/01/2020108,000
Metzger Michael APresident and COO12/01/2020344,513
Ordentlich PeterChief Scientific Officer11/23/202092,314
Ordentlich PeterChief Scientific Officer11/23/2020694,121
Morrison BriggsChief Executive Officer11/10/2020125,755
Morrison BriggsChief Executive Officer11/09/2020453,154
Morrison BriggsChief Executive Officer11/10/2020350,312
Morrison BriggsChief Executive Officer11/09/20201,261,265
Metzger Michael APresident and COO11/04/2020720,000
Metzger Michael APresident and COO11/04/20202,031,410
Shea Richard PChief Financial Officer07/31/20196,851
Shea Richard PChief Financial Officer01/31/202011,995
Morrison BriggsChief Executive Officer02/04/2020100,000
Morrison BriggsChief Executive Officer10/10/201959,400
Morrison BriggsChief Executive Officer05/13/201952,517
Morrison BriggsChief Executive Officer05/09/201999,726
Meyers Michael L.SVP, Chief Medical Officer03/21/201939
Meyers Michael L.SVP, Chief Medical Officer03/21/20195,436
Shea Richard PChief Financial Officer01/31/201912,000
Meyers Michael L.SVP, Chief Medical Officer01/31/201917,707
Metzger Michael APresident and COO01/31/201912,657
Meyers Michael L.SVP, Chief Medical Officer10/30/2018958
Ordentlich PeterChief Scientific Officer04/03/201823,100
Ordentlich PeterChief Scientific Officer04/03/2018112,500
Ordentlich PeterChief Scientific Officer05/17/20172,255
Ordentlich PeterChief Scientific Officer05/17/201775,000
ROYSTON IVORDirector03/20/20171,718,750
ROYSTON IVORDirector03/08/20161,800,000
Load More Insider Transactions
FUNDS WITH A POSITION IN SYNDAX PHARMACEUTICALS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.7,015,5480.00387%19.26%Other
ORBIMED ADVISORS LLC1,749,0000.75%36.21%Other
GEODE CAPITAL MANAGEMENT, LLC1,535,0550.00347%12.8%Other
CANDRIAM S.C.A.1,021,0320.15%325.41%Other
ADAGE CAPITAL PARTNERS GP, L.L.C.900,0000.04%-10%Other
PALO ALTO INVESTORS LP472,6000.92%No changeOther
RENAISSANCE TECHNOLOGIES LLC218,3000.0054%ExitedOther
BALYASNY ASSET MANAGEMENT L.P.165,0180.0067%11.11%Event Driven
D. E. SHAW & CO., INC.41,9650.00079%-71.75%Other
UBS OCONNOR LLC95,9490.15%NewValue
UBS OCONNOR LLC75,000 (Call)0.02%-6.25%Value
TUDOR INVESTMENT CORP ET AL68,9810.01%130.41%Event Driven, Other
ALPS ADVISORS INC48,1260.00818%-6.07%Other
AQR CAPITAL MANAGEMENT LLC35,9020.00146%46.11%Other
FARALLON CAPITAL MANAGEMENT LLC10,0000.00107%NewEvent Driven, Value
FISHER ASSET MANAGEMENT, LLC1470%ExitedOther
CHANGE IN SHARES OUTSTANDING FOR SYNDAX PHARMACEUTICALS INC
STOCK BUYBACKS FOR SYNDAX PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
3.85%
1Q
12/31/2023
06/30/2023
4.17%
2Q
12/31/2023
03/31/2023
4.47%
3Q
12/31/2023
12/31/2022
14.75%
4Q
12/31/2023
09/30/2022
19.57%
5Q
12/31/2023
06/30/2022
20.59%
6Q
12/31/2023
03/31/2022
23.00%
7Q
12/31/2023
12/31/2021
22.09%
8Q
12/31/2023
09/30/2021
39.61%
9Q
12/31/2023
06/30/2021
40.58%
10Q
12/31/2023
03/31/2021
40.86%
11Q
12/31/2023
12/31/2020
57.40%
12Q
12/31/2023
09/30/2020
64.29%
13Q
12/31/2023
06/30/2020
78.64%
14Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
3.85%
1Q
06/30/2023
4.17%
2Q
03/31/2023
4.47%
3Q
12/31/2022
14.75%
4Q
09/30/2022
19.57%
5Q
06/30/2022
20.59%
6Q
03/31/2022
23.00%
7Q
12/31/2021
22.09%
8Q
09/30/2021
39.61%
9Q
06/30/2021
40.58%
10Q
03/31/2021
40.86%
11Q
12/31/2020
57.40%
12Q
09/30/2020
64.29%
13Q
06/30/2020
78.64%
14Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR SYNDAX PHARMACEUTICALS INC
LOADING...